Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
bardoxolone methyl (formerly RTA 402)
Also known as: CDDO-Me
print preview
bookmark
share with colleague
General Information
Company
Reata Pharmaceuticals Inc.
Description
Small molecule activator of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)
Molecular Target
Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2)
;
Signal transducer and activator of transcription 3 (STAT3)
Mechanism of Action
NF-kappa B (NF-kB) inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy